Terbinafine Hydrochloride Tablet
Product Images NDC 68071-2381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 68071-2381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2381 3)

Pdp (68071 2381 3)
Terbinafine 250 mg Tablets prescription label from NuCare Pharmaceuticals, Inc. The label indicates a package containing 30 oral tablets. It features barcodes, lot and expiration placeholders (00000, 00-00), manufacturing details from Cipla Ltd., Verna Goa, India, and standard warnings including storage instructions and keeping out of reach of children.*
FDA Label Image

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 01)

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 01)
Chemical structure of Terbinafine Hydrochloride, depicting the molecular connectivity with aromatic rings, multiple carbon-carbon bonds, and a hydrochloride moiety indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.